P38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 28, 2012, Pages 11200-11205

  Risco, Ana ^a   Del Dresno, Carlosdel ^a   Mambol, Agnes ^b   Alsina Beauchamp, Dayanira ^a   MacKenzie, Kirsty F ^c   Yang, Huei Ting ^b   Barber, Domingo F ^a   Morcelle, Carmen ^a   Arthur, J Simon C ^c   Ley, Steven C ^b   Ardavin, Carlos ^a   Cuenda, Ana ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P38 DELTA; P38 GAMMA; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROGRESSION LOCUS 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE DELETION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; STEADY STATE;

ANIMALS; CATTLE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 13; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; SHOCK, SEPTIC; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84863936555     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1207290109     Document Type: Article

References (38)

1. Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19(1):24-32. (Pubitemid 46498752)
2. Lee MS, Kim YJ (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76:447-480.
3. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773:1358-1375. (Pubitemid 47125981)
4. Gaestel M, Kotlyarov A, Kracht M (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov 8:480-499.
5. Adams RH, et al. (2000) Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6(1):109-116.
6. Mudgett JS, et al. (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459.
7. Tamura K, et al. (2000) Requirement for p38alpha in erythropoietin expression: A role for stress kinases in erythropoiesis. Cell 102:221-231.
8. Kang YJ, et al. (2008) Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J Immunol 180:5075-5082.
9. Kim C, et al. (2008) The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol 9:1019-1027.
10. Otsuka M, et al. (2010) Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 138(4):1255-1265, 1265.e1-9.
11. Beardmore VA, et al. (2005) Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 25:10454-10464. (Pubitemid 41681967)
12. Sumara G, et al. (2009) Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 136:235-248.
13. Gillespie MA, et al. (2009) p38-gamma-dependent gene silencing restricts entry into the myogenic differentiation program. J Cell Biol 187:991-1005.
14. Schindler EM, et al. (2009) p38delta mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res 69:4648-4655.
15. Cerezo-Guisado MI, et al. (2011) Evidence of p38γ and p38δ involvement in cell transformation processes. Carcinogenesis 32:1093-1099.
16. Fearns C, et al. (2000) Coordinate activation of endogenous p38alpha, beta, gamma, and delta by inflammatory stimuli. J Leukoc Biol 67:705-711.
17. Hale KK, Trollinger D, Rihanek M, Manthey CL (1999) Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 162:4246-4252. (Pubitemid 29314814)
18. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765. (Pubitemid 32368050)
19. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511. (Pubitemid 38931765)
20. Gantke T, Sriskantharajah S, Ley SC (2011) Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase. Cell Res 21(1):131-145.
21. Dumitru CD, et al. (2000) TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103:1071-1083. (Pubitemid 32040907)
22. Eliopoulos AG, Wang CC, Dumitru CD, Tsichlis PN (2003) Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J 22:3855-3864. (Pubitemid 36975712)
23. Beinke S, et al. (2003) NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol Cell Biol 23:4739-4752. (Pubitemid 36793322)
24. Papoutsopoulou S, et al. (2006) ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat Immunol 7:606-615. (Pubitemid 43797342)
25. Waterfield MR, Zhang M, Norman LP, Sun SC (2003) NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol Cell 11:685-694. (Pubitemid 36385122)
26. Beinke S, Robinson MJ, Hugunin M, Ley SC (2004) Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105. Mol Cell Biol 24:9658-9667. (Pubitemid 39391700)
27. Waterfield M, Jin W, Reiley W, Zhang M, Sun SC (2004) IkappaB kinase is an essential component of the Tpl2 signaling pathway. Mol Cell Biol 24:6040-6048. (Pubitemid 38787986)
28. Lang V, et al. (2004) ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol 24:5235-5248. (Pubitemid 38738159)
29. Das S, et al. (2005) Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner. J Biol Chem 280:23748-23757.
30. Wellbrock C, Karasarides M, Marais R (2004) The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5:875-885. (Pubitemid 39486539)
31. Mielke LA, et al. (2009) Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production. J Immunol 183:7984-7993.
32. Rousseau S, et al. (2008) TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages. J Cell Sci 121(2):149-154. (Pubitemid 351228446)
33. Soond SM, Everson B, Riches DW, Murphy G (2005) ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118:2371-2380. (Pubitemid 40873077)
34. Kaiser F, et al. (2009) TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J Exp Med 206:1863-1871.
35. Zhang Y, Saccani S, Shin H, Nikolajczyk BS (2008) Dynamic protein associations define two phases of IL-1beta transcriptional activation. J Immunol 181:503-512.
36. Cohen P (2009) Targeting protein kinases for the development of anti-inflammatory drugs. Curr Opin Cell Biol 21:317-324.
37. Genovese MC (2009) Inhibition of p38: Has the fat lady sung? Arthritis Rheum 60: 317-320.
38. Hume DA, et al. (1985) Preparation and characterization of human bone marrow-derived macrophages. J Leukoc Biol 38:541-552. (Pubitemid 16256751)